Koshinski Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Koshinski Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,054	Closed	-$94.4K	–	660
2022 Q1	$94.4K	Buy	2,054 +311	+18%	+$14.8K	0.01%	851
2021 Q4	$107K	Sell	1,743 -752	-30%	-$52K	0.01%	834
2021 Q3	$186K	Buy	+2,495	New	+$209K	0.02%	631
2021 Q1	–	Sell	-4,357	Closed	-$406K	–	590
2020 Q4	$406K	Buy	4,357 +892	+26%	+$71.1K	0.05%	366
2020 Q3	$254	Buy	+3,465	New	+$203K	0.03%	433

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Koshinski Asset Management's ARKG Position: Q2 2022 in Review

Koshinski Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 2,054 shares — an estimated $94.4K sold.

Koshinski Asset Management first reported a position in ARKG in Q3 2020 and held it in 5 quarters. The position peaked at $406K in Q4 2020. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Koshinski Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Koshinski Asset Management sold 2,054 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $94.4K.
Koshinski Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 5 quarters.
Koshinski Asset Management's ARK Genomic Revolution ETF position peaked at $406K in Q4 2020.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.